236 related articles for article (PubMed ID: 29557079)
1. Perinatal Outcomes of Women Diagnosed with Attention-Deficit/Hyperactivity Disorder: An Australian Population-Based Cohort Study.
Poulton AS; Armstrong B; Nanan RK
CNS Drugs; 2018 Apr; 32(4):377-386. PubMed ID: 29557079
[TBL] [Abstract][Full Text] [Related]
2. Prescription Stimulant Use During Pregnancy and Risk of Neurodevelopmental Disorders in Children.
Suarez EA; Bateman BT; Hernandez-Diaz S; Straub L; McDougle CJ; Wisner KL; Gray KJ; Pennell PB; Lester B; Zhu Y; Mogun H; Huybrechts KF
JAMA Psychiatry; 2024 May; 81(5):477-488. PubMed ID: 38265792
[TBL] [Abstract][Full Text] [Related]
3. Placental Complications Associated With Psychostimulant Use in Pregnancy.
Cohen JM; Hernández-Díaz S; Bateman BT; Park Y; Desai RJ; Gray KJ; Patorno E; Mogun H; Huybrechts KF
Obstet Gynecol; 2017 Dec; 130(6):1192-1201. PubMed ID: 29112657
[TBL] [Abstract][Full Text] [Related]
4. Patterns of psychostimulant prescribing to children with ADHD in Western Australia: variations in age, gender, medication type and dose prescribed.
Preen DB; Calver J; Sanfilippo FM; Bulsara M; Holman CD
Aust N Z J Public Health; 2007 Apr; 31(2):120-6. PubMed ID: 17461001
[TBL] [Abstract][Full Text] [Related]
5. Association of Attention-Deficit/Hyperactivity Disorder With Teenage Birth Among Women and Girls in Sweden.
Skoglund C; Kopp Kallner H; Skalkidou A; Wikström AK; Lundin C; Hesselman S; Wikman A; Sundström Poromaa I
JAMA Netw Open; 2019 Oct; 2(10):e1912463. PubMed ID: 31577361
[TBL] [Abstract][Full Text] [Related]
6. Association of maternal attention deficit hyperactivity disorder and preterm birth: a cohort study.
Hesselman S; Wikman A; Skoglund C; Kopp Kallner H; Skalkidou A; Sundström-Poromaa I; Wikström AK
BJOG; 2020 Nov; 127(12):1480-1487. PubMed ID: 32384173
[TBL] [Abstract][Full Text] [Related]
7. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
J Dev Behav Pediatr; 2014 Sep; 35(7):448-57. PubMed ID: 25180895
[TBL] [Abstract][Full Text] [Related]
8. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
J Dev Behav Pediatr; 2006 Feb; 27(1):1-10. PubMed ID: 16511362
[TBL] [Abstract][Full Text] [Related]
9. Attention-Deficit Hyperactivity Disorder (ADHD) Medication Use Trajectories Among Women in the Perinatal Period.
Bang Madsen K; Bliddal M; Skoglund CB; Larsson H; Munk-Olsen T; Madsen MG; Hove Thomsen P; Bergink V; Srinivas C; Cohen JM; Brikell I; Liu X
CNS Drugs; 2024 Apr; 38(4):303-314. PubMed ID: 38489019
[TBL] [Abstract][Full Text] [Related]
10. Environmental risk factors by gender associated with attention-deficit/hyperactivity disorder.
Silva D; Colvin L; Hagemann E; Bower C
Pediatrics; 2014 Jan; 133(1):e14-22. PubMed ID: 24298003
[TBL] [Abstract][Full Text] [Related]
11. Patterns of long-term ADHD medication use in Australian children.
Efron D; Mulraney M; Sciberras E; Hiscock H; Hearps S; Coghill D
Arch Dis Child; 2020 Jun; 105(6):593-597. PubMed ID: 31937570
[TBL] [Abstract][Full Text] [Related]
12. Use of prescription stimulant for Attention Deficit Hyperactivity Disorder in Aboriginal children and adolescents: a linked data cohort study.
Ghosh M; Holman CD; Preen DB
BMC Pharmacol Toxicol; 2015 Dec; 16():35. PubMed ID: 26646429
[TBL] [Abstract][Full Text] [Related]
13. Methylparaben in meconium and risk of maternal thyroid dysfunction, adverse birth outcomes, and Attention-Deficit Hyperactivity Disorder (ADHD).
Baker BH; Wu H; Laue HE; Boivin A; Gillet V; Langlois MF; Bellenger JP; Baccarelli AA; Takser L
Environ Int; 2020 Jun; 139():105716. PubMed ID: 32283359
[TBL] [Abstract][Full Text] [Related]
14. Cocaine or Methamphetamine Use During Young Adulthood Following Stimulant Use for Attention-Deficit/Hyperactivity Disorder During Adolescence.
McCabe SE; Schulenberg JE; Wilens TE; Schepis TS; McCabe VV; Veliz PT
JAMA Netw Open; 2023 Jul; 6(7):e2322650. PubMed ID: 37432689
[TBL] [Abstract][Full Text] [Related]
15. Use of medication by young people with attention-deficit/hyperactivity disorder.
Sawyer MG; Rey JM; Graetz BW; Clark JJ; Baghurst PA
Med J Aust; 2002 Jul; 177(1):21-5. PubMed ID: 12088474
[TBL] [Abstract][Full Text] [Related]
16. Maternal and neonatal outcomes after exposure to ADHD medication during pregnancy: A systematic review and meta-analysis.
Jiang HY; Zhang X; Jiang CM; Fu HB
Pharmacoepidemiol Drug Saf; 2019 Mar; 28(3):288-295. PubMed ID: 30585374
[TBL] [Abstract][Full Text] [Related]
17. Prescribed stimulant use by Western Australians with Attention Deficit Hyperactivity Disorder (ADHD): does amount dispensed exceed the expected authorised use?
Calver J; Sanfilippo F; Preen D; Bulsara M
Aust N Z J Public Health; 2007 Dec; 31(6):533-9. PubMed ID: 18081573
[TBL] [Abstract][Full Text] [Related]
18. Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design.
Raman SR; Marshall SW; Haynes K; Gaynes BN; Naftel AJ; Stürmer T
Inj Prev; 2013 Jun; 19(3):164-70. PubMed ID: 23143347
[TBL] [Abstract][Full Text] [Related]
19. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
[TBL] [Abstract][Full Text] [Related]
20. ADHD, stimulant treatment, and growth: a longitudinal study.
Harstad EB; Weaver AL; Katusic SK; Colligan RC; Kumar S; Chan E; Voigt RG; Barbaresi WJ
Pediatrics; 2014 Oct; 134(4):e935-44. PubMed ID: 25180281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
